These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| x | Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
| For the quarterly period ended: September 30, 2010 |
| o | Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
| For the transition period from to . |
| Delaware | 04-2959321 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 64 Jackson Road, Devens, Massachusetts | 01434 | |
| (Address of principal executive offices) | (Zip Code) |
| Large accelerated filer x | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o | |||
| (Do not check if a smaller reporting company) | ||||||
| Common Stock, par value $0.01 per share | 46,051,793 | |
| Class | Outstanding as of November 1, 2010 | |
2
| September 30, | March 31, | |||||||
| 2010 | 2010 | |||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 52,615 | $ | 87,594 | ||||
|
Marketable securities
|
69,218 | 54,469 | ||||||
|
Accounts receivable, net
|
96,042 | 62,203 | ||||||
|
Inventory
|
45,241 | 35,858 | ||||||
|
Prepaid expenses and other current assets
|
21,357 | 15,381 | ||||||
|
Restricted cash
|
5,484 | 5,713 | ||||||
|
Deferred tax assets
|
3,117 | 1,776 | ||||||
|
|
||||||||
|
Total current assets
|
293,074 | 262,994 | ||||||
|
|
||||||||
|
Property, plant and equipment, net
|
78,160 | 64,315 | ||||||
|
Goodwill
|
47,508 | 36,696 | ||||||
|
Intangibles, net
|
7,966 | 7,770 | ||||||
|
Marketable securities
|
3,900 | 7,342 | ||||||
|
Deferred tax assets
|
4,121 | 3,043 | ||||||
|
Other assets
|
30,506 | 18,024 | ||||||
|
|
||||||||
|
|
||||||||
|
Total assets
|
$ | 465,235 | $ | 400,184 | ||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
||||||||
|
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 94,184 | $ | 84,319 | ||||
|
Deferred revenue
|
25,113 | 19,970 | ||||||
|
Deferred tax liabilities
|
1,580 | 471 | ||||||
|
|
||||||||
|
Total current liabilities
|
120,877 | 104,760 | ||||||
|
|
||||||||
|
Deferred revenue
|
16,433 | 13,302 | ||||||
|
Deferred tax liabilities
|
1,929 | 777 | ||||||
|
Other
|
418 | 380 | ||||||
|
|
||||||||
|
Total liabilities
|
139,657 | 119,219 | ||||||
|
|
||||||||
|
|
||||||||
|
Commitments and contingencies (Note 10)
|
||||||||
|
|
||||||||
|
Stockholders equity:
|
||||||||
|
Common stock
|
456 | 448 | ||||||
|
Additional paid-in capital
|
718,411 | 698,417 | ||||||
|
Accumulated other comprehensive loss
|
(1,557 | ) | (7,011 | ) | ||||
|
Accumulated deficit
|
(391,732 | ) | (410,889 | ) | ||||
|
|
||||||||
|
Total stockholders equity
|
325,578 | 280,965 | ||||||
|
|
||||||||
|
|
||||||||
|
Total liabilities and stockholders equity
|
$ | 465,235 | $ | 400,184 | ||||
|
|
||||||||
3
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Revenues
|
$ | 101,529 | $ | 74,672 | $ | 198,739 | $ | 147,672 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Cost and operating expenses:
|
||||||||||||||||
|
Cost of revenues
|
60,226 | 45,637 | 118,450 | 96,054 | ||||||||||||
|
Research and development
|
7,857 | 5,416 | 15,192 | 9,944 | ||||||||||||
|
Selling, general and administrative
|
17,127 | 12,712 | 32,310 | 23,597 | ||||||||||||
|
Amortization of acquisition related intangibles
|
374 | 460 | 762 | 905 | ||||||||||||
|
Restructuring and impairments
|
| 117 | | 451 | ||||||||||||
|
|
||||||||||||||||
|
Total cost and operating expenses
|
85,584 | 64,342 | 166,714 | 130,951 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Operating income
|
15,945 | 10,330 | 32,025 | 16,721 | ||||||||||||
|
|
||||||||||||||||
|
Interest income
|
191 | 190 | 367 | 433 | ||||||||||||
|
Other income (expense), net
|
2,448 | (871 | ) | 2,618 | (2,847 | ) | ||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Income before income tax expense
|
18,584 | 9,649 | 35,010 | 14,307 | ||||||||||||
|
|
||||||||||||||||
|
Income tax expense
|
8,596 | 5,309 | 15,853 | 8,175 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net income
|
$ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net income per common share
|
||||||||||||||||
|
Basic
|
$ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||||
|
|
||||||||||||||||
|
Diluted
|
$ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||||
|
|
||||||||||||||||
|
Weighted average number of common shares outstanding
|
||||||||||||||||
|
Basic
|
45,482 | 44,247 | 45,363 | 44,020 | ||||||||||||
|
|
||||||||||||||||
|
Diluted
|
46,217 | 45,233 | 46,099 | 44,922 | ||||||||||||
|
|
||||||||||||||||
4
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Net income
|
$ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||
|
Foreign currency translation
|
16,525 | 3,248 | 4,190 | 7,305 | ||||||||||||
|
Unrealized gains on cash flow hedges
|
1,463 | - | 1,319 | - | ||||||||||||
|
Unrealized losses on investments
|
(33 | ) | (19 | ) | (55 | ) | (110 | ) | ||||||||
|
|
||||||||||||||||
|
Total other comprehensive income, net of tax
|
17,955 | 3,229 | 5,454 | 7,195 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Comprehensive income
|
$ | 27,943 | $ | 7,569 | $ | 24,611 | $ | 13,327 | ||||||||
|
|
||||||||||||||||
5
| Six months ended | ||||||||
| September 30, | ||||||||
| 2010 | 2009 | |||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$ | 19,157 | $ | 6,132 | ||||
|
Adjustments to reconcile net income to net cash (used in) provided by
operations:
|
||||||||
|
Depreciation and amortization
|
5,428 | 4,704 | ||||||
|
Stock-based compensation expense
|
7,825 | 6,918 | ||||||
|
Stock-based compensation expensenon-employee
|
181 | 30 | ||||||
|
Allowance for doubtful accounts
|
959 | 52 | ||||||
|
Deferred income taxes
|
(71 | ) | (1,111 | ) | ||||
|
Other non-cash items
|
1,107 | 382 | ||||||
|
Changes in operating asset and liability accounts:
|
||||||||
|
Accounts receivable
|
(36,953 | ) | 3,010 | |||||
|
Inventory
|
(8,934 | ) | 6,235 | |||||
|
Prepaid expenses and other current assets
|
(6,408 | ) | 712 | |||||
|
Accounts payable and accrued expenses
|
8,011 | (4,810 | ) | |||||
|
Deferred revenue
|
7,820 | (567 | ) | |||||
|
|
||||||||
|
|
||||||||
|
Net cash (used in) provided by operating activities
|
(1,878 | ) | 21,687 | |||||
|
|
||||||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property, plant and equipment
|
(17,950 | ) | (2,741 | ) | ||||
|
Purchase of marketable securities
|
(25,283 | ) | (40,533 | ) | ||||
|
Proceeds from the maturity of marketable securities
|
15,482 | 33,374 | ||||||
|
Change in restricted cash
|
253 | (546 | ) | |||||
|
Purchase of intangible assets
|
(1,615 | ) | (843 | ) | ||||
|
Purchase of minority investment
|
(8,000 | ) | - | |||||
|
Change in other assets
|
(182 | ) | (617 | ) | ||||
|
|
||||||||
|
|
||||||||
|
Net cash used in investing activities
|
(37,295 | ) | (11,906 | ) | ||||
|
|
||||||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from exercise of employee stock options and ESPP
|
1,574 | 4,068 | ||||||
|
|
||||||||
|
|
||||||||
|
Net cash provided by financing activities
|
1,574 | 4,068 | ||||||
|
|
||||||||
|
|
||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
2,620 | 2,229 | ||||||
|
|
||||||||
|
|
||||||||
|
Net (decrease) increase in cash and cash equivalents
|
(34,979 | ) | 16,078 | |||||
|
|
||||||||
|
Cash and cash equivalents at beginning of period
|
87,594 | 70,674 | ||||||
|
|
||||||||
|
|
||||||||
|
Cash and cash equivalents at end of period
|
$ | 52,615 | $ | 86,752 | ||||
|
|
||||||||
|
|
||||||||
|
Supplemental schedule of cash flow information:
|
||||||||
|
Non-cash contingent consideration in connection with acquisitions
|
$ | 10,003 | $ | 10,828 | ||||
|
Cash paid for income taxes
|
6,925 | 2,531 | ||||||
|
Non-cash issuance of common stock
|
419 | 320 | ||||||
6
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Cost of revenues
|
$ | 452 | $ | 354 | $ | 835 | $ | 579 | ||||||||
|
Research and development
|
691 | 523 | 1,159 | 990 | ||||||||||||
|
Selling, general and administrative
|
3,183 | 2,975 | 5,831 | 5,349 | ||||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 4,326 | $ | 3,852 | $ | 7,825 | $ | 6,918 | ||||||||
|
|
||||||||||||||||
7
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Expected volatility
|
61.5 | % | 66.5 | % | 65.6 | % | 70.2 | % | ||||||||
|
Risk-free interest rate
|
1.6 | % | 2.4 | % | 2.1 | % | 2.6 | % | ||||||||
|
Expected life (years)
|
6.2 | 4.8 | 6.2 | 4.8 | ||||||||||||
|
Dividend yield
|
None | None | None | None | ||||||||||||
8
| For the three months ended | For the six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net income
|
$ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Denominator:
|
||||||||||||||||
|
Weighted-average shares of common stock outstanding
|
45,694 | 44,299 | 45,597 | 44,080 | ||||||||||||
|
Weighted-average shares subject to repurchase
|
(212 | ) | (52 | ) | (234 | ) | (60 | ) | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Shares used in per-share calculation basic
|
45,482 | 44,247 | 45,363 | 44,020 | ||||||||||||
|
Dilutive effect of employee equity incentive plans
|
735 | 986 | 737 | 902 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Shares used in per-share calculation diluted
|
46,217 | 45,233 | 46,099 | 44,922 | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net income per share basic
|
$ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net income per share diluted
|
$ | 0.22 | $ | 0.10 | $ | 0.42 | $ | 0.14 | ||||||||
|
|
||||||||||||||||
| Level 1 - |
Inputs are unadjusted quoted prices in active markets for
identical assets or liabilities that the Company has the
ability to access at the measurement date.
|
| Level 2 - |
Inputs include quoted prices for similar assets and liabilities
in active markets, quoted prices for identical or similar
assets or liabilities in markets that are not active, inputs
other than quoted prices that are observable for the asset or
liability, and inputs that are derived principally from or
corroborated by observable market data by correlation or other
means (market corroborated inputs).
|
| Level 3 - |
Unobservable inputs that reflect the Companys assumptions that
market participants would use in pricing the asset or
liability. The Company develops these inputs based on the best
information available, including its own data.
|
9
| Total | Quoted Prices in | Using Significant Other | Using Significant | |||||||||||||
| Carrying | Active Markets | Observable Inputs | Unobservable Inputs | |||||||||||||
| Value | ( Level 1) | ( Level 2) | ( Level 3) | |||||||||||||
|
September 30, 2010:
|
||||||||||||||||
|
Cash equivalents
|
$ | 7,524 | $ | 7,524 | $ | | $ | | ||||||||
|
Derivatives
|
2,450 | | 2,450 | | ||||||||||||
|
Short-term marketable securities
|
69,218 | | 69,218 | | ||||||||||||
|
Long-term marketable securities
|
3,900 | | 3,900 | | ||||||||||||
| Total | Quoted Prices in | Using Significant Other | Using Significant | |||||||||||||
| Carrying | Active Markets | Observable Inputs | Unobservable Inputs | |||||||||||||
| Value | ( Level 1) | ( Level 2) | ( Level 3) | |||||||||||||
|
March 31, 2010:
|
||||||||||||||||
|
Cash equivalents
|
$ | 29,054 | $ | 29,054 | $ | | $ | | ||||||||
|
Derivatives
|
168 | | 168 | | ||||||||||||
|
Short-term marketable securities
|
54,469 | | 54,469 | | ||||||||||||
|
Long-term marketable securities
|
7,342 | | 7,342 | | ||||||||||||
10
| Asset derivatives | Liability derivatives | |||||||||||||||
| September 30, | March | September 30, | ||||||||||||||
| 2010 | 31, 2010 | 2010 | March 31, 2010 | |||||||||||||
|
Derivatives designated as cash flow hedges
|
$ | 1,561 | $ | | $ | | $ | | ||||||||
|
Derivatives not designated as cash flow hedges
|
889 | 168 | | | ||||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 2,450 | $ | 168 | $ | | $ | | ||||||||
|
|
||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| September | September 30, | September | September | |||||||||||||
| 30, 2010 | 2009 | 30, 2010 | 30, 2009 | |||||||||||||
|
Gains recognized in other comprehensive income
|
$ | 1,950 | $ | | $ | 1,758 | $ | | ||||||||
|
The Company recognized the following pre-tax gains related to forward foreign exchange contracts
not designated as cash flow hedges (in thousands):
|
||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| September | September 30, | September | September 30, | |||||||||||||
| 30, 2010 | 2009 | 30, 2010 | 2009 | |||||||||||||
|
Gains recognized in other expense, net
|
$ | 7,994 | $ | 403 | $ | 3,975 | $ | 139 | ||||||||
|
Gains recognized in cost of revenues
|
440 | $ | | 440 | $ | | ||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 8,434 | $ | 403 | $ | 4,415 | $ | 139 | ||||||||
|
|
||||||||||||||||
11
| September 30, | March 31, | |||||||
| 2010 | 2010 | |||||||
|
Accounts receivable (billed)
|
$ | 93,941 | $ | 53,430 | ||||
|
Accounts receivable (unbilled)
|
4,964 | 10,305 | ||||||
|
Less: Allowance for doubtful accounts
|
(2,863 | ) | (1,532 | ) | ||||
|
|
||||||||
|
Accounts receivable, net
|
$ | 96,042 | $ | 62,203 | ||||
|
|
||||||||
| September 30, | March 31, | |||||||
| 2010 | 2010 | |||||||
|
Raw materials
|
$ | 20,919 | $ | 18,065 | ||||
|
Work-in-process
|
5,668 | 7,318 | ||||||
|
Finished goods
|
14,886 | 7,879 | ||||||
|
Deferred program costs
|
3,768 | 2,596 | ||||||
|
|
||||||||
|
Net inventory
|
$ | 45,241 | $ | 35,858 | ||||
|
|
||||||||
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Balance at beginning of period
|
$6,375 | $5,325 | $6,431 | $4,749 | ||||||||||||
|
Accruals for warranties during the period
|
2,020 | 1,602 | 4,332 | 2,717 | ||||||||||||
|
Settlements and adjustments during the period
|
(1,021) | (1,430) | (3,389) | (1,969) | ||||||||||||
|
|
||||||||||||||||
|
Balance at end of period
|
$7,374 | $5,497 | $7,374 | $5,497 | ||||||||||||
|
|
||||||||||||||||
12
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Costs incurred
|
$ | 499 | $ | 1,004 | $ | 1,024 | $ | 2,475 | ||||||||
|
R&D expenditures offset by cost sharing funding received
|
133 | 227 | 274 | 617 | ||||||||||||
|
SG&A expenditures offset by cost sharing funding received
|
116 | 198 | 238 | 538 | ||||||||||||
13
|
Balance at March 31, 2010
|
$ | 36,696 | ||
|
Contingent consideration
|
10,003 | |||
|
Net foreign exchange rate impact
|
809 | |||
|
|
||||
|
|
||||
|
Balance at September 30, 2010
|
$ | 47,508 | ||
|
|
||||
14
|
Purchase of minority investment
|
$ | 8,000 | ||
|
Minority interest in net losses
|
(212) | |||
|
Net foreign exchange rate impact
|
546 | |||
|
|
||||
|
Balance at September 30, 2010
|
$ | 8,334 | ||
|
|
||||
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Revenues
:
|
||||||||||||||||
|
AMSC Power Systems
|
$98,540 | $71,791 | $193,468 | $142,487 | ||||||||||||
|
AMSC Superconductors
|
2,989 | 2,881 | 5,271 | 5,185 | ||||||||||||
|
|
||||||||||||||||
|
Total
|
$101,529 | $74,672 | $198,739 | $147,672 | ||||||||||||
|
|
||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Operating income
:
|
||||||||||||||||
|
AMSC Power Systems
|
$26,842 | $19,866 | $52,327 | $35,261 | ||||||||||||
|
AMSC Superconductors
|
(6,533 | ) | (5,647 | ) | (12,444 | ) | (11,144 | ) | ||||||||
|
Unallocated corporate
expenses
|
(4,364 | ) | (3,889 | ) | (7,858 | ) | (7,396 | ) | ||||||||
|
|
||||||||||||||||
|
Total
|
$15,945 | $10,330 | $32,025 | $16,721 | ||||||||||||
|
|
||||||||||||||||
15
| September 30, | March 31, | |||||||
| 2010 | 2010 | |||||||
|
AMSC Power Systems
|
$ | 256,790 | $ | 179,873 | ||||
|
AMSC Superconductors
|
45,547 | 32,978 | ||||||
|
Corporate assets
|
162,898 | 187,333 | ||||||
|
|
||||||||
|
Total
|
$ | 465,235 | $ | 400,184 | ||||
|
|
||||||||
16
| ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
17
18
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Revenues
:
|
||||||||||||||||
|
AMSC Power Systems
|
$ | 98,540 | $ | 71,791 | $ | 193,468 | $ | 142,487 | ||||||||
|
AMSC Superconductors
|
2,989 | 2,881 | 5,271 | 5,185 | ||||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 101,529 | $ | 74,672 | $ | 198,739 | $ | 147,672 | ||||||||
|
|
||||||||||||||||
19
| Revenue earned for | Revenue earned for | |||||||||||||||||||||||
| the three months | the six months | |||||||||||||||||||||||
| Revenue earned | ended September 30, | ended September 30, | ||||||||||||||||||||||
| Expected total | through | |||||||||||||||||||||||
| Project name | contract value | September 30, 2010 | 2010 | 2009 | 2010 | 2009 | ||||||||||||||||||
|
HYDRA
|
$ | 24,908 | $ | 10,082 | $ | 388 | $ | 565 | $ | 509 | $ | 829 | ||||||||||||
|
LIPA I and II
|
40,141 | 36,499 | 1,366 | 932 | 2,148 | 1,639 | ||||||||||||||||||
|
DOE-FCL
|
7,898 | 5,393 | 416 | 515 | 987 | 577 | ||||||||||||||||||
|
NAVSEA Motor Study
|
6,511 | 6,361 | 42 | 59 | 149 | 74 | ||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Total
|
$ | 79,458 | $ | 58,335 | $ | 2,212 | $ | 2,071 | $ | 3,793 | $ | 3,119 | ||||||||||||
|
|
||||||||||||||||||||||||
20
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
R&D expenses per condensed consolidated
statements of income
|
$ | 7,857 | $ | 5,416 | $ | 15,192 | $ | 9,944 | ||||||||
|
R&D expenditures reclassified as cost of revenues
|
2,510 | 1,360 | 5,879 | 2,847 | ||||||||||||
|
R&D expenditures offset by cost-sharing funding
|
133 | 227 | 274 | 617 | ||||||||||||
|
|
||||||||||||||||
|
Aggregated R&D expenses
|
$ | 10,500 | $ | 7,003 | $ | 21,345 | $ | 13,408 | ||||||||
|
|
||||||||||||||||
21
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
AMSC Power Systems
|
$ | 26,842 | $ | 19,866 | $ | 52,327 | $ | 35,261 | ||||||||
|
AMSC Superconductors
|
(6,533) | (5,647) | (12,444) | (11,144) | ||||||||||||
|
Unallocated corporate expenses
|
(4,364) | (3,889) | (7,858) | (7,396) | ||||||||||||
|
|
||||||||||||||||
|
Total
|
$ | 15,945 | $ | 10,330 | $ | 32,025 | $ | 16,721 | ||||||||
|
|
||||||||||||||||
22
| Three months ended | Six months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||
|
Net income
|
$ | 9,988 | $ | 4,340 | $ | 19,157 | $ | 6,132 | ||||||||
|
Amortization of acquisition-related intangibles
|
374 | 460 | 762 | 905 | ||||||||||||
|
Restructuring and impairments
|
| 117 | | 451 | ||||||||||||
|
Stock-based compensation
|
4,326 | 3,852 | 7,825 | 6,918 | ||||||||||||
|
Tax effects
|
(84 | ) | (93 | ) | (167 | ) | (181 | ) | ||||||||
|
|
||||||||||||||||
|
Non-GAAP net income
|
$ | 14,604 | $ | 8,676 | $ | 27,577 | $ | 14,225 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Non-GAAP earnings per share
|
$ | 0.32 | $ | 0.19 | $ | 0.60 | $ | 0.32 | ||||||||
|
|
||||||||||||||||
|
Weighted average diluted shares outstanding
|
46,217 | 45,233 | 46,099 | 44,922 | ||||||||||||
|
|
||||||||||||||||
23
| September 30, | March 31, | |||||||
| 2010 | 2010 | |||||||
|
Cash and cash equivalents
|
$ | 52,615 | $ | 87,594 | ||||
|
Marketable securities (short and long-term)
|
73,118 | 61,811 | ||||||
|
Restricted cash
|
5,484 | 5,713 | ||||||
|
|
||||||||
|
Total cash, cash equivalents, marketable securities and restricted cash
|
$ | 131,217 | $ | 155,118 | ||||
|
|
||||||||
24
| ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
25
| ITEM 4. | CONTROLS AND PROCEDURES |
26
| ITEM 1A. | RISK FACTORS |
| ITEM 6. | EXHIBITS |
27
|
AMERICAN SUPERCONDUCTOR CORPORATION
|
||||||
|
|
||||||
|
Date: November 4, 2010
|
By: | /s/ David A. Henry | ||||
|
|
David A. Henry
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
|||||
28
| Exhibit No. | Description | |
|
|
||
|
10.1
|
Purchase
Contract No. HCG1.5MW-10016-01, effective as of May 12, 2010, between
Sinovel Wind Group Co., Ltd. and Suzhou AMSC Superconductor Co.,
Ltd (1)
|
|
|
|
||
|
31.1
|
Chief Executive OfficerCertification pursuant to
Rule 13a-14(a) or Rule 15d-14(a) of the Securities
Exchange Act of 1934, as adopted pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
||
|
31.2
|
Chief Financial OfficerCertification pursuant to
Rule 13a-14(a) or Rule 15d-14(a) of the Securities
Exchange Act of 1934, as adopted pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
||
|
32.1
|
Chief Executive OfficerCertification pursuant to
Rule 13a-14(b) or Rule 15d-14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
||
|
32.2
|
Chief Financial OfficerCertification pursuant to
Rule 13a-14(b) or Rule 15d-14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
|
|
|
|
||
|
|
||
|
101.INS
|
XBRL Instance Document.** | |
|
|
||
|
101.SCH
|
XBRL Taxonomy Extension Schema Document.**
|
|
|
|
||
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document.**
|
|
|
|
||
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document.**
|
|
|
|
||
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document.**
|
|
|
|
| (1) | Incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K/A filed with the Commission on September 15, 2010 (Commission file No. 000-19672). | |
| | Confidential treatment previously requested and granted with respect to certain portions, which portions were omitted and filed separately with the Commission. | |
| ** | submitted electronically herewith |
29
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|